OncoSil Medical managing director and CEO Nigel Lange said, “The results of this important analysis highlight the superiority of the OncoSil device compared to Stereotactic Body Radiation Therapy, which is considered to be the best available system for delivering external beam radiotherapy to patients with locally advanced pancreatic cancer. …
OncoSil Medical reports positive results of pancreatic cancer analysis
May 7, 2025 Australian Biotech
Latest Video
New Stories
-
Percheron Therapeutics launches bonus loyalty option offer
May 7, 2025 - - Australian Biotech -
OncoSil Medical reports positive results of pancreatic cancer analysis
May 7, 2025 - - Australian Biotech -
CLINUVEL recruits 200 patients for Phase 3 vitiligo trial of SCENESSE
May 7, 2025 - - Australian Biotech -
Pharmacy Guild calls for standardisation of access to asthma treatment
May 6, 2025 - - Latest News -
Trump administration moves to streamline pharma manufacturing while increasing global inspections
May 6, 2025 - - Latest News -
Sigma delivers continued growth following the completion of Chemist Warehouse merger
May 6, 2025 - - Latest News -
Greg Hunt to chair new telehealth sector working group
May 6, 2025 - - Latest News